Erik Tambuyzer
From Wikipedia, the free encyclopedia
Dr. Erik Tambuyzer (b. 1949) is a Belgian bio-engineer and businessman. He is Senior Vice President Corporate Affairs for Genzyme Europe and International, and a member of the European Management Committee of Genzyme Corporation.
[edit] Education
Dr. Tambuyzer is a bio-engineer and holds a doctoral degree in bio-industrial sciences from the Katholieke Universiteit Leuven, (Leuven, Belgium).
[edit] Career
He started his professional career at Baxter Healthcare (Baxter-Travenol in Europe) in 1977, he pursued his career six years later at Innovi NV (Brussels, Belgium), a technology management and consultancy company. He also worked as a consultant on biotechnology for minister-president Gaston Geens of the Flemish government. In 1985 he made the business plan and co-founded, together with Hugo Van Heuverswyn, the healthcare biotech company Innogenetics NV (Ghent, Belgium), of which he has been General Manager until 1992, at which time he joined Genzyme.
Dr. Tambuyzer is a founding Board member and past Chairman of EuropaBio, the European Association for Bioindustries, and founder of the Ethics Working Group of this Association, as well as the Chair of the joint EBE/EFPIA-EuropaBio Orphan medicines Task Force. He is also Vice-Chair of EPPOSI, the European Platform for Patients’ Organizations, Science & Industry. He published on policies regarding orphan medicines and advanced therapies in Europe and internationally, as well as about the European Clinical Trial Directive, and the impact of biotechnology on healthcare systems. From October 2000 until October 2002, Dr. Tambuyzer was Chairman of the Board of EuropaBio, the European Association for Bioindustries.
[edit] Source
This Belgian biographical article is a stub. You can help Wikipedia by expanding it.
